Sigma trial results in diabetes opportunities

The results of Sigma's ‘first-to-market’ trial of in-pharmacy HbA1c testing in selected Amcal and Guardian stores show the test provides more opportunities for pharmacists to engage with diabetes patients and those at risk of the disease, the company says. Previously un-trialled within the Australian pharmacy channel, the test identifies blood sugar control over a specified

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous 'Change the damn colour of folate tablets already': best reader comments
Next Choosing the right destination